|
Haroon MZ, Farooq U, Ashraf S, Zeb S, Gillani SY, Malik S, Ali R, Irshad R, Mehmood Z, Abbas Y, Masood A, Ghafoor A, Khalil AT, Asif H, Khan S, Ujjan ID, Nigar R, Livingstone S, Pascual-Figal DA, Togni S, Allergini P, Riva A, Khan A. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial. J Physiol Pharmacol. 2022 Jun;73(3). doi: 10.26402/jpp.2022.3.09. Epub 2022 Oct 22. PubMed PMID: 36302537.
AÑO: 2022; IF: 2.2
|
36302537
|
Gonzalez-Del-Hoyo M, Rodriguez-Leor O, Cid-Alvarez AB, de Prado AP, Ojeda S, Serrador A, Lopez-Palop R, Martin-Moreiras J, Rumoroso JR, Cequier A, Ibanez B, Cruz-Gonzalez I, Romaguera R, Raposeiras-Roubin S, Moreno R, Rossello X; Working Group on the Infarct Code of the Interventional Cardiology Association of the Spanish Society of Cardiology (Grupo de Trabajo de Codigo Infarto de la Asociacion de Cardiologia Intervencionista de la Sociedad Espanola de Cardiologia). Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort. Int J Cardiol. 2022 Nov 15;367:90-98. doi: 10.1016/j.ijcard.2022.08.036. Epub 2022 Aug 25. PubMed PMID: 36030132.
AÑO: 2022; IF: 3.5
|
|
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabes JA, Sanchez PL, Anguita M, Fernandez-Vazquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Perez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Aguero J, Pocock S, Ottani F, Fuster V, Ibanez B; REBOOT-CNIC investigators. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. PubMed PMID: 34351426.
AÑO: 2022; IF: 7.1
|
|
Rao SV, Kirsch B, Bhatt DL, Budaj A, Coppolecchia R, Eikelboom J, James SK, Jones WS, Merkely B, Keller L, Hermanides RS, Campo G, Ferreiro JL, Shibasaki T, Mundl H, Alexander JH; PACIFIC AMI Investigators. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction. Circulation. 2022 Oct 18;146(16):1196-1206. doi: 10.1161/CIRCULATIONAHA.122.061612. Epub 2022 Aug 27. Erratum In: Circulation. 2022 Dec 6;146(23):e330. PubMed PMID: 36030390.
AÑO: 2022; IF: 37.8
|
|
Caravaca Perez P, Gonzalez-Juanatey JR, Nuche J, Matute-Blanco L, Serrano I, Martinez Selles M, Vazquez Garcia R, Martinez Dolz L, Gomez-Bueno M, Pascual Figal D, Crespo-Leiro MG, Garcia-Osuna A, Ordonez-Llanos J, Cinca Cuscullola J, Guerra JM, Delgado JF. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure. Front Cardiovasc Med. 2022 Apr 7;9:861651. doi: 10.3389/fcvm.2022.861651. eCollection 2022. PubMed PMID: 35463785; PubMed Central PMCID: PMC9021836.
AÑO: 2022; IF: 3.6
|